Bibliographic Info
GuidelineWHO guidelines for malaria, 30 November 2024.
Year of Publication2024
Issuing InstitutionWHO
Recommendation
Status
Updated
Recommended in favor
Strong
Certainty of evidence
Moderate
To prevent relapse, children and adult (except pregnant women, infants aged < 1 months and women breastfeeding infants aged < 1 months, and people with glucose-6-phosphate dehydrogenase (G6PD) deficiency), primaquine should be given at a high total dose (7 mg/kg) at 0.5 mg/ kg/day for 14 days or 1 mg/kg/day for 7 days for prevention of relapses in patients with uncomplicated P. vivax or P. ovale malaria.